Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jul 15, 2015 · 10-Q · 45 days after period end · 0001557240-15-000518
| Metric | Q3 2015 | Q3 2014 |
|---|---|---|
| Net Income | -$2.50K | -$8.15K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended May 31, 2015 · filed Jul 15, 2015 · 45 d after period end
